Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Ethics consent

Expert Panel Report to the National Institutes of Health (NIH) (1998) Research involving individuals with questionable capacity to consent ethical issues and practical considerations for institutional review boards (IRBs). Presented In Bethesda, MD, February 1998. [Pg.744]

Jackson, G. (2006b). Mental health screening in the schools Essentials of informed consent. Ethical Human Psychology and Psychiatry, 8, 217-224. [Pg.492]

Despite the principle of informed consent, ethical difficulties in human research remain. After all, when a new drug is developed, someone has to be the first person to take it. Even though federal law says that a drug must be tested extensively in animals before it is tried with people, some side effect not detected in the animal studies could still occur. [Pg.121]

Coy JA. Autonomy-based informed consent ethical implications for patient non-compliance. Phys Ther 1989 69 826-833. [Pg.472]

Unlike human trials. Institutional Review Boards/Independent Ethics Committees are not involved, while informed consent is only required from the owner of the trial animals. In addition to the standard items associated with human trials, aspects such as management and housing of animals, diet and disposal of trial animals and their produce should be included in the trial protocol. Studies may be blinded from the investigators in order to avoid bias in the reporting of animal observations. [Pg.134]

While there is no FDA involvement in such investigations, ethical considerations and institutional regulations would generally dictate that informed consent and the approval of the local institutional review board be obtained. However, due to the negligible risks involved these are likely to be a formality and will not involve extensive review or scrutiny. [Pg.192]

The consent form is a document to be used to acquire the consent of worker volunteers to become a part of a worker exposure study or re-entry exposure study and is an integral part of ensuring the ethical integrity of the research project. This form is normally in English but should be translated into Spanish or any other language... [Pg.998]

Review of the consent form by ethical review boards... [Pg.999]

Most consent forms that have been developed have at some time been reviewed by standing ethical review boards, usually associated with a university. The format of the consent form described above has been reviewed over time by more than one ethical review board and would be acceptable in most States for the purpose of acquiring the consent of potential volunteers in a worker exposure or re-entry study. If performing worker exposure studies in California, the researcher is advised to contact the State regulatory agencies and submit the draft consent form and study protocol to the State-appointed ethical review board for review and approval prior to initiation of the field phase of the study. Of course, if the researcher has any doubt about the acceptability of the proposed consent form, he/she should contact the appropriate state agencies where they plan to perform the study. [Pg.999]

Is placebo surgery ethical Should doctors be allowed to administer anaesthesia and make surgical incisions, but then not do any therapeutic intervention Isn t the first rule of medicine to do no harm It is true that informed consent is now required in clin-... [Pg.115]

This suggestion of group consent kicked off a lively debate that, five years later, persists in the literature of research ethics. The North American Committee s position has found many opponents (National Research... [Pg.75]

Several other chapters in this book address ethical issues, which are essential for the educational programs. Pharmacogenomic analyses will multiply the challenges of explaining available tests and gaining informed consent to perform each test. In some cases, patients or relatives will be asked... [Pg.158]

Although there are several ethical concerns with biobanks and other large-scale research repositories (Rothstein, 2002), the most important issue is informed consent. Participants in research involving human subjects must be advised of the intended research to be performed with their specimens. With biobanks, however, the future research uses of the samples are unknown at the time of collection. It would be infeasible to contact each of the donors to obtain consent every time a new research use is contemplated, yet IRBs are reluctant to approve the use of blanket consent for unspecified uses. One way to avoid this problem is for prospective sample donors to be given a menu of possible uses of their samples. Such a list might include research in mental health, HIV/AIDS, cancer, cardiovascular disease, or other areas. The donors would then have the opportunity to approve the use of their specimens for all or some of the listed uses. Other disclosures necessary to obtain informed consent include the financial interests of the biobank and researchers, whether individuals may elect to be notified of research findings, and whether it is possible for an individual to withdraw his or her sample from the bank (Rothstein, 2002). [Pg.319]

Family and friends can be incredibly helpful resources in treatment if the client has a good relationship with them. As mentioned in Chapter 1, if the client has strained relationships with a certain family member or friend, it may not be wise to include that person if his or her participation threatens the client. In other instances, the client simply may not want the person to be involved. Therapists and clients should make certain that the client does want family members and friends involved prior to a therapists or counselors contacting them. Ethically speaking, it is important to respect the wishes of your client with regard to collateral involvement in therapy or treatment. Legally speaking, it is important for consent to be provided by the client for a therapist or counselor to speak with collaterals or to involve them in the therapy process. [Pg.166]

Ethical issues surrounding the design and conduct of genetic research with people, including the process of informed consent. [Pg.48]

Medical research is subject to ethical standards that promote respect for all human beings and protect their health and rights. Some research populations are vulnerable and need special protection. The particular needs of the economically and medically disadvantaged must be recognized. Special attention is also required for those who cannot give or refuse consent for themselves, for those who may be subject to giving consent under duress, for those who will not benefit personally from the research, and for those for whom the research is combined with care. [Pg.180]

Regulatory authorities stipulate the need for ethical principles to be observed when conducting clinical trials. Clinical trials should never be conducted to gain knowledge per se. They should be based on risk-benefit considerations, informed consent, and respect for human individuals. Furthermore, subjects should be protected without being taken advantage of. [Pg.204]

As discussed in Section 4.7, stem cells have the potential to treat medical conditions beyond the scope that can be offered by drugs alone. However, there are many scientific and ethical hurdles to overcome. On the scientific front, stem cell research activities will intensify over the next decade. These challenges can broadly be divided into (1) determining how to develop stem cells into specific tissues and (2) implanting these tissues into the body without rejection by the recipient s immune system. On the ethical front, it is expected that there will be more debates on the ethical issues of stem cell research. Most scientists consent to therapeutic cloning (stem cell research) but not reproductive cloning. The ethical issue of stem cell research concerns harvesting cells from embryos that are a few days old. This action destroys the embryos. Some questions are ... [Pg.368]

This volume contains frank discussion of the ethical compass that guided our work, particularly with respect to informed consent. Some chapters describe, and occasionally take issue with comments appearing in both military and civilian publications, particularly between 1965 and 1982, when public concern about the Army s testing of drugs in human volunteers dramatically escalated. [Pg.7]

The American Medical Association s (AMA) General Statement on Informed Consent, Code of Medical Ethics ... [Pg.48]

For discussions concerning informed consent and medical experimentation on prison populations, see Mark, Vernon H, Neville, Robert, (1977) Brain Surgery in Aggressive Epileptics Social and Ethical Implications. Ethical Issues in Modern Medicine, (eds, Robert Hunt John Arras). Veatch, Robert M, (1977). Case Studies In Medical Ethics, pp, 267-71 Bernier, Barbara L, (1994) Class, Race, And Poverty Medical Technologies And Socio-Political Choices. 11 Harv. BlackLetter J. 115,... [Pg.49]

Detailed written information, which generally constitutes part of the consent form, should not be provided to potential volunteers until ethics approval has been obtained. A checklist of the items that should be covered in the volunteer information is given in Box 4.8. Most importantly, the information should be provided in clear non-technical language. ... [Pg.156]

In addition to ARSAC approval, the protocol must also be approved by ethics committees in the normal manner for studies in man. The study should be conducted in between four and eight consenting subjects, in facilities where any spills of radiolabelled materials can be contained and monitored. Normally, subjects will be required to provide blood samples and to collect all excreta for a period determined by the known or estimated half-lives of the parent compound and metabolite. With cooperative subjects, recoveries of radioactivity should be close to 100%. Samples will be assayed for radioactivity and by cold chromatographic methods, and every attempt should be made to identify major metabolites... [Pg.191]

The Helsinki Declaration covers all the important ethical considerations, such as the involvement of a qualified physician in any clinical trial, putting the well-being of the study subject before science and society, the use of scientific principles in the design of the study, the need for informed consent and a review by an ethics review committee in fact, all areas covered by the ICH GCP. [Pg.239]


See other pages where Ethics consent is mentioned: [Pg.254]    [Pg.321]    [Pg.254]    [Pg.321]    [Pg.188]    [Pg.190]    [Pg.249]    [Pg.70]    [Pg.127]    [Pg.140]    [Pg.125]    [Pg.75]    [Pg.101]    [Pg.197]    [Pg.199]    [Pg.318]    [Pg.786]    [Pg.7]    [Pg.427]    [Pg.427]    [Pg.428]    [Pg.429]    [Pg.441]    [Pg.261]    [Pg.48]    [Pg.159]    [Pg.204]    [Pg.246]    [Pg.257]   


SEARCH



Consent

Enforcing Your Rights Medical Ethics, Consent, Privacy, and IT

Ethical considerations informed consent

Ethical issues informed consent

Ethical/legal issues informed consent

Informed consent ethical basis

Informed consent, clinical trials ethics committees

© 2026 chempedia.info